Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;167(6):923-928.
doi: 10.1177/01945998221075610. Epub 2022 Feb 1.

COVID-19 Tracheostomy Outcomes

Affiliations

COVID-19 Tracheostomy Outcomes

Nicole Molin et al. Otolaryngol Head Neck Surg. 2022 Dec.

Abstract

Objectives: (1) Assess overall COVID-19 mortality in ventilated patients with and without tracheostomy. (2) Determine the impact of tracheostomy on mechanical ventilation duration, overall length of stay (LOS), and intensive care unit (ICU) LOS for patients with COVID-19.

Study design: Case series with planned chart review.

Setting: Single-institution tertiary care center.

Methods: Patients with COVID-19 who were ≥18 years old and requiring invasive positive pressure ventilation (IPPV) met inclusion criteria. Patients were stratified into 2 cohorts: IPPV with tracheostomy and IPPV with intubation only. Cohorts were analyzed for the following primary outcome measures: mortality, LOS, ICU LOS, and IPPV duration.

Results: An overall 258 patients with IPPV met inclusion criteria: 46 (18%) with tracheostomy and 212 (82%) without (66% male; median age, 63 years [interquartile range, 18.75]). Average LOS, time in ICU, and time receiving IPPV were longer in the tracheostomy cohort (P < .01). Ability to wean from IPPV was similar between cohorts (P > .05). The number of deaths in the nontracheostomy cohort (54%) was significantly higher than the tracheostomy cohort (29%, P < .01).

Conclusions: While tracheostomy placement in patients with COVID-19 did not shorten overall LOS, mechanical ventilation duration, or ICU LOS, patients with a tracheostomy experienced a significantly lower number of deaths vs those without. One goal for tracheostomy is improved pulmonary toilet with associated shortened IPPV requirements. Our study did not identify this advantage among the COVID-19 population. However, this study demonstrates that the need for tracheostomy in the COVID-19 setting does not portent a poor prognostic factor, as patients with a tracheostomy experienced a significantly higher survival rate than their nontracheostomy counterparts.

Keywords: COVID-19; mechanical ventilation; tracheostomy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Cecelia E. Schmalbach—AAO-HNS/F coordinator for research and quality; Otolaryngology–Head and Neck Surgery, editorial board and editor in chief–elect; teaching honorarium, AO North America CMF (nonprofit trauma teaching consortium).

Sponsorships: None.

Funding source: None.

References

    1. Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. - PMC - PubMed
    1. Bice T, Nelson JE, Carson SS. To trach or not to trach: uncertainty in the care of the chronically critically ill. In: Seminars in Respiratory and Critical Care Medicine. Vol 36. Thieme Medical Publishers; 2015:851-858. - PMC - PubMed
    1. Heyd CP, Desiato VM, Nguyen SA, et al.. Tracheostomy protocols during COVID-19 pandemic. Head Neck. 2020;42(6):1297-1302. - PMC - PubMed
    1. Chao TN, Harbison SP, Braslow BM, et al.. Outcomes after tracheostomy in COVID-19 patients. Ann Surg. 2020;272(3):e181. - PMC - PubMed
    1. Kwak PE, Connors JR, Benedict PA, et al.. Early outcomes from early tracheostomy for patients with COVID-19. JAMA Otolaryngol Neck Surg. 2021;147(3):239-244. - PMC - PubMed